Have a personal or library account? Click to login
Thimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study Cover

Thimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study

Open Access
|Mar 2016

References

  1. American Academy of Pediatrics. (1999). Thimerosal in vaccines – An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health. Pediatrics104: 570–574.
  2. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth edition). Washington, DC, American Psychiatric Association.
  3. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. (2004). Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics114: 584–591.
  4. Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW. (2012). Thimerosal exposure in early life and neuropsychological outcomes 7–10 years later. Journal of Pediatric Psychology37: 106–118.
  5. Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, Visser S, Kogan MD. (2011). Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics 127(6): 1034–1042.
  6. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. (2005). Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect113: 1015–1021.
  7. Castellanos FX, Margulies DS, Kelly C, Uddin LQ, Ghaffari M, Kirsch A, Shaw D, Shehzad Z, Di Martino A, Biswal B, Sonuga-Barke EJ, Rotrosen J, Adler LA, Milham MP. (2008). Cingulate-precuneus interactions: a new locus of dys-function in adult attention-deficit/hyperactivity disorder. Biol Psychiatry63(3): 332–337.
  8. Centers for Disease Control. (1991). Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep40(RR-13): 1–25.
  9. Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Ward JI, Marcy SM. (2000). The vaccine safety datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ78(2): 186–194.
  10. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC. (1997). Vaccine Safety Datalink: project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics99(6): 765–773.
  11. Church JA, Fair DA, Dosenbach NU, Cohen Al, Miezin FM, Petersen SE, Schlaggar BL. (2009). Control networks in paediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain132: 225–238.
  12. Cubo E. (2012). Review of prevalence studies of tic disorders: methodological caveats. Tremor Other Hyperkinet Mov (N Y) 2: pii: tre-02-61-349-1.
  13. DeStefano F, Vaccine Safety Datalink Research Group. (2001). The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Safe10: 403–406.
  14. Ellenberg SS, Braun MM. (2002). Monitoring the safety of vaccinees: assessing the risks. Drug Safety25: 145–152.
  15. Fair DA, Dosenbach NU, Church JA, Cohen AL, Brahmbhatt S, Miezin FM, Barch DM, Raichle ME, Petersen SE, Schlaggar BL. (2007). Development of distinct control networks through segregation and integration. Proc Natl Acad Sci U S A104: 13507–13512.
  16. Fawcett JW. (1992). Intrinsic neuronal determinants of regeneration. Trends in Neurosci15: 5–8.
  17. Fine PE, Chen RT. (1992). Confounding in studies of adverse reactions to vaccines. Am J Epidemiol136: 121–135.
  18. Freeman RD, Tourette Syndrome International Database Consortium. (2007). Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry16(Suppl 1): 15–23.
  19. Geier MR, Geier DA. (2002). The state of polio vaccination in the world: the case for continuing routine vaccination. Toxicol Mech Methods12: 221–228.
  20. Geier DA, Geier MR. (2004). A review of the Vaccine Adverse Event Reporting System database. Expert Opin Pharmacother5: 691–698.
  21. Geier DA, Geier MR. (2005). A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit11: CR160–CR170.
  22. Geier DA, Geier MR. (2006). A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett27(4): 401–413.
  23. Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR. (2013). A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Transl Neurodegener2: 25.
  24. Grzadzinski R, Di Martino A, Brady E, Mairena MA, O’Neale M, Petkova E, Lord C, Castellanos FX (2011). Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD? J Autism Dev Disord41(9): 1178–1191.10.1007/s10803-010-1135-3312340121108041
  25. Hariz MI, Robertson MM. (2010). Gilles de la Tourette syndrome and deep brain stimulation. Eur J Neurosci32: 1128–1134.
  26. Jones TA. (1999). Multiple synapse formation in the motor cortex opposite uni-lateral sensorimotor cortex lesions in adult rats. J Comp Neurol414: 57–66.
  27. Jones TA, Schallert T. (1992). Overgrowth and pruning of dendrites in adult rats recovering from neocortical damage. Brain Res581: 156–160.
  28. Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR. (2012). Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiol Exp (War)72: 113–153.
  29. Kern JK, Geier DA, Ayzac F, Adams JB, Mehta JA, Geier MR. (2011). Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins. Toxicol Environ Chem93: 396–405.
  30. Kern JK, Geier DA, Sykes LK, Geier MR, Deth RC. (2015). Are ASD and ADHD a continuum? A comparison of pathophysiological similarities between the disorders. J Atten Disord19(9): 805–27.
  31. Kern JK, Haley BE, Geier DA, Sykes LK, King PG, Geier MR. (2013). Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism. Int J Environ Res Public Health10: 3771–3800.
  32. Laks DR. (2009). Assessment of chronic mercury exposure within the U.S. population, National Health and Nutrition Examination Survey, 1999–2006. Biometals22: 1103–1114.
  33. Li AM, Chan MH, Leung TF, Cheung RC, Lam CW, Fok TF. (2000). Mercury intoxication present with tics. Arch Dis Childhood83: 174–175.
  34. Liu Y, Miao W, Wang J, Gao P, Yin G, Zhang L, Lv C, Ji Z, Yu T, Sabel BA, He H, Peng Y. (2013). Structural abnormalities in early Tourette syndrome children: a combined voxel-based morphometry and tract-based spatial statistics study. PLoS One8(9): e76105.
  35. Marques RC, Dórea JG, Fonseca MF, Bastos WR, Malm O. (2007). Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines. Eur J Pediatr166(9): 935–941.
  36. National Institute of Neurological Disorders and Stroke. National Institutes of Health. Tourette Syndrome Fact Sheet 2013 [updated 10/19/2012]. Available from [accessed on: 4/12/2014]: http://www.ninds.nih.gov/disorders/tourette/detail_tourette.htm#220453231.
  37. Neuner I, Kupriyanova Y, Stöcker T, Huang R, Posnansky O, Schneider F, Tittgemeyer M, Shah NJ. (2010). White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage51(3): 1184–1193.
  38. Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J. (2008). Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics121(2): e208–e214.
  39. Pichichero ME, Gentile A, Giglio N, Alonso MM, Fernandez Mentaberri MV, Zareba G, Clarkson T, Gotelli C, Gotelli M, Yan L, Treanor J. (2009). Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines. J Pediatr155(4): 495–499.
  40. Redwood L, Bernard S, Brown D. (2001). Predicted mercury concentrations in hair from infant immunizations: cause for concern. Neurotoxicology22: 691–697.
  41. Roessner V, Hoekstra PJ, Rothenberger A. (2011). Tourette’s disorder and other tic disorders in DSM-5: a comment. Eur Child Adolesc Psychiatry20: 71–74.
  42. Stajich GV, Lopez GP, Harry SW, Sexson WR. (2000). Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr136: 679–681.
  43. Tan M, Parkin JE. (2000). Route of decomposition of thiomersal (thimerosal). Int J Pharm208: 23–34.
  44. Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, et al. (2007). Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med357: 1281–1292.
  45. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT; Vaccine Safety Datalink Team. (2003). Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics112: 1039–1048.
  46. Wang L, Zhu C, He Y, Zang Y, Cao Q, Zhang H, Zhong Q, Wang Y. (2009). Altered small-world brain functional networks in children with attention-deficit/hyperactivity disorder. Hum Brain Mapp30: 638–649.
  47. Wass S. (2011). Distortions and disconnections: disrupted brain connectivity in autism. Brain Cogn75: 18–28.
  48. Wassilak SG, Glasser JW, Chen RT, Hadler SC. (1995). Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann NY Acad Sci754: 377–382.
  49. Wehe CA, Pieper I, Holtkamp M, Thyssen GM, Sperling M, Schwerdtle T, Karst U. (2014). On-line species-unspecific isotope dilution analysis in the picomolar range reveals the time- and species-depending mercury uptake in human astrocytes. Anal Bioanal Chem406(7): 1909–1916.
  50. Young HA, Geier DA, Geier MR. (2008). Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci271: 110–118.
  51. Zimmermann LT, Santos DB, Naime AA, Leal RB, Dórea JG, Barbosa F Jr, Aschner M, Rocha JB, Farina M. (2013). Comparative study on methyl- and ethyl-mercury-induced toxicity in C6 glioma cells and the potential role of LAT-1 in mediating mercurial-thiol complexes uptake. Neurotoxicology38: 1–8.
DOI: https://doi.org/10.1515/intox-2015-0011 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 68 - 76
Submitted on: Feb 12, 2015
|
Accepted on: Apr 23, 2015
|
Published on: Mar 7, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 David A. Geier, Janet K. Kern, Brian S. Hooker, Paul G. King, Lisa K. Sykes, Kristin G. Homme, Mark R. Geier, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.